Recombinant Staphylococcus aureus 50S ribosomal protein L10 (rplJ)

How does rplJ function within the bacterial ribosome?

rplJ serves multiple crucial functions within the bacterial ribosome:

• Structural role: It acts as a scaffold protein that helps stabilize the central protuberance of the 50S ribosomal subunit.

• Assembly factor: It facilitates the correct assembly of the large ribosomal subunit by interacting with both rRNA and neighboring ribosomal proteins.

• Translational regulation: It participates in the regulation of protein synthesis by influencing ribosomal dynamics during translation.

• Antibiotic interaction site: The region surrounding rplJ can be involved in interactions with certain antibiotics, making it relevant to antimicrobial resistance studies .

The protein's positioning near the peptidyl transferase center (PTC) makes it particularly significant for understanding mechanisms of protein synthesis and antibiotic action.

How conserved is rplJ across bacterial species?

rplJ demonstrates high sequence conservation across diverse bacterial species, particularly in domains that interact with rRNA and other essential ribosomal components. Sequence alignment studies reveal:

This high degree of conservation reflects the protein's essential role in ribosome function across bacterial species. The conserved nature of rplJ makes it possible to apply findings from S. aureus to other bacterial systems, although species-specific variations must be considered when interpreting experimental results across different organisms .

What are the optimal conditions for expression and purification of recombinant S. aureus rplJ?

For optimal expression and purification of recombinant S. aureus rplJ, the following methodological approach is recommended:

Expression System:

• Yeast expression systems have proven effective for recombinant production .

• E. coli BL21(DE3) can also be used with pET expression vectors containing the rplJ gene.

Expression Conditions:

• Induction with 0.5-1.0 mM IPTG when using E. coli systems

• Growth at 30°C rather than 37°C can improve soluble protein yield

• Expression time of 4-6 hours post-induction is typically optimal

Purification Protocol:

• Cell lysis using sonication in buffer containing 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 10 mM imidazole, and protease inhibitors

• Initial purification via Ni-NTA affinity chromatography if using His-tagged constructs

• Secondary purification using ion-exchange chromatography

• Final polishing step with size-exclusion chromatography to achieve >85% purity

Storage Recommendations:

• Store at -20°C for short-term usage

• For extended storage, maintain at -80°C

• Addition of 5-50% glycerol (final concentration) is recommended to preserve stability

• Avoid repeated freeze-thaw cycles

Quality Control:

• Verify purity via SDS-PAGE (expected >85%)

• Confirm identity through mass spectrometry

• Assess functionality through ribosome binding assays

How can researchers effectively validate the functionality of purified recombinant rplJ?

Validating the functionality of purified recombinant rplJ requires multiple complementary approaches:

Structural Integrity Assessment:

• Circular dichroism (CD) spectroscopy to confirm proper protein folding

• Size-exclusion chromatography to verify monomeric state and absence of aggregation

• Limited proteolysis to examine domain organization

Functional Assays:

• Ribosome Assembly Assay: Measure the ability of purified rplJ to incorporate into ribosomal subunits in vitro

• rRNA Binding Assay: Assess interaction with 23S rRNA fragments using electrophoretic mobility shift assays (EMSA)

• Protein-Protein Interaction Analysis: Use pull-down assays to confirm interactions with other ribosomal proteins like L7/L12

In vitro Translation System:

• Reconstitution experiments with 50S subunits lacking rplJ, followed by functional translation assays

• Measure the restoration of protein synthesis activity in the presence of purified recombinant rplJ

Controls to Include:

• Denatured rplJ (negative control)

• Native ribosomal extract containing rplJ (positive control)

• Structure-altering mutations in key functional domains (validation controls)

Implementing these validation steps ensures that the purified recombinant protein maintains native functionality and can be reliably used in downstream experimental applications .

What experimental design is most appropriate for studying rplJ's role in antibiotic resistance mechanisms?

To study rplJ's role in antibiotic resistance mechanisms, a true experimental research design is most appropriate, with the following structured approach:

Experimental Design Elements:

• Manipulation of Independent Variable: Generate specific mutations in rplJ or modify its expression levels

• Random Assignment: Use multiple S. aureus strains randomly assigned to different experimental groups

• Control Groups: Include wild-type S. aureus strains and known antibiotic-resistant mutants

• Dependent Variables: Measure antibiotic susceptibility, ribosome function, and fitness costs

Recommended Methodological Framework:

• Site-Directed Mutagenesis Studies:

  • Create targeted mutations in rplJ based on structural analysis

  • Test mutations that alter interaction with antibiotics or rRNA

  • Compare with previously identified resistance-conferring mutations in other ribosomal components (e.g., G2576T mutation in 23S rRNA)

• Gene Expression Modulation:

  • Develop strains with controlled expression of rplJ (under- and over-expression)

  • Use inducible promoter systems for precise temporal control

  • Monitor effects on antibiotic susceptibility under varying expression levels

• Structural Studies:

  • Employ cryo-EM or X-ray crystallography to examine the structural impact of mutations

  • Focus on interactions with oxazolidinones and other ribosome-targeting antibiotics

  • Compare with structures from resistant clinical isolates

• Serial Passage Experiments:

  • Subject S. aureus cultures to increasing antibiotic concentrations

  • Sequence rplJ and related genes to identify emerging mutations

  • Compare mutation frequency to other ribosomal genes (rplC, rplD)

• Spontaneous Mutation Analysis:

  • Calculate and compare mutation frequencies across different antibiotics

  • Identify hotspots for resistance-conferring mutations in rplJ

This comprehensive experimental design allows for rigorous investigation of causal relationships between rplJ mutations and antibiotic resistance while controlling for confounding variables .

How is rplJ being utilized in experimental vaccine development against S. aureus?

rplJ has emerging applications in S. aureus vaccine development strategies, building on advances with other ribosomal proteins:

Current Research Approaches:

• Recombinant rplJ as Immunogen:

  • Expression of rplJ with lipidation modifications enhances immunogenicity

  • Similar to findings with other S. aureus proteins, lipidated recombinant forms can elicit stronger antibody responses

  • The conserved nature of rplJ makes it a potential cross-reactive antigen across different S. aureus strains

• Adjuvant Properties Exploration:

  • Research indicates recombinant lipidated bacterial proteins can function as effective adjuvants

  • rplJ may serve dual roles as both immunogen and immune response enhancer

  • This approach parallels successful work with other S. aureus immune evasion proteins like FLIPr

• Mucosal Immunity Applications:

  • Formulations containing rplJ are being investigated for enhancing mucosal immunity

  • This is particularly relevant for preventing nasal colonization, which is a major risk factor for S. aureus infections

  • Studies show that appropriate delivery systems can induce both systemic and mucosal antibody responses

Experimental Findings from Related Studies:

• Recombinant lipidated proteins from S. aureus have demonstrated potent immunostimulatory properties

• Similar approaches with FLIPr elicited long-lasting antigen-specific immune responses

• Enhanced mucosal and systemic antibody responses were observed with appropriately formulated antigens

While direct studies on rplJ as a vaccine candidate are still emerging, its essential nature, conservation across strains, and surface accessibility make it a promising target for future vaccine development efforts.

What is the role of rplJ in ribosomal mutation studies relating to antibiotic resistance?

rplJ plays a significant role in ribosomal mutation studies related to antibiotic resistance, particularly in understanding the complex mechanisms of oxazolidinone resistance:

Key Research Findings:

• Resistance Mechanism Elucidation:

  • While direct mutations in rplJ are less common than in other ribosomal components, its proximity to key resistance sites makes it important for comprehensive resistance studies

  • Changes in rplJ can influence the binding of antibiotics like linezolid and TR-700 (torezolid) to their target sites

  • Research shows that mutations in 23S rRNA (G2447T, T2500A, G2576T) and ribosomal proteins L3 (rplC) and L4 (rplD) are more frequently associated with oxazolidinone resistance

• Resistance Mutation Profiling:

  • Serial passage experiments with increasing antibiotic concentrations have identified specific mutation patterns

  • TR-700-selected mutants displayed T2500A and novel T2571C/G2576T coupled mutations

  • Linezolid-selected mutants showed G2447T, T2500A, and G2576T mutations

• Structural Impact Analysis:

  • Crystal structure analysis using LZD-bound 50S ribosomal subunit data reveals how mutations affect antibiotic binding

  • Researchers use coordinates from Deinococcus radiodurans and Haloarcula marismortui structures to deduce effects in S. aureus

  • The high conservation of these regions allows for cross-species structural analysis

Methodological Approaches:

• PCR amplification of rrn operons containing 5S, 16S, and 23S rRNA genes

• Amplification of PTC-associated ribosomal proteins (L3, L4, L22) using specific primers

• Structural analysis using PyMOL with crystallographic data

Understanding the interplay between rplJ and other ribosomal components provides critical insights into resistance mechanisms and guides the development of new antibiotics with improved activity against resistant strains.

How is rplJ being utilized in promoter engineering for recombinant protein production?

Recent research has demonstrated valuable applications of rplJ in promoter engineering for enhanced recombinant protein production:

Research Applications:

• Development of Constitutive Promoter Libraries:

  • The promoter region of rplJ (P_RplJ) has been identified as a strong constitutive promoter in bacterial expression systems

  • In Serratia marcescens JNB5-1, P_RplJ was successfully used to develop a well-characterized constitutive promoter library

  • This represents the first such library derived from rplJ in S. marcescens

• Enhancement of Secondary Metabolite Production:

  • The rplJ promoter was effectively employed to overexpress transcription factors OmpR and PsrA

  • In S. marcescens, this approach resulted in a 1.62-fold increase in prodigiosin production (from 6.33 g/L to 10.25 g/L)

  • The recombinant strain (PG-6) demonstrated significantly improved production capabilities

• Transcription Factor Engineering:

  • rplJ promoter-driven expression of regulatory proteins offers a strategy for metabolic engineering

  • Research shows this approach can be combined with other engineering strategies for synergistic effects

Experimental Results and Engineering Parameters:

This approach has broad potential applications beyond prodigiosin production, potentially applicable to other high-value products in various bacterial expression systems .

What are the interactions between rplJ mutations and 23S rRNA mutations in conferring antibiotic resistance?

The interaction between rplJ mutations and 23S rRNA mutations represents a complex area of research in understanding multi-factorial antibiotic resistance mechanisms:

Current Understanding:

• Synergistic Effects:

  • While direct mutations in rplJ are less commonly reported in resistance studies, its proximity to 23S rRNA resistance hotspots suggests potential interaction effects

  • Research indicates that combinations of mutations in ribosomal proteins and rRNA can produce synergistic increases in resistance levels

  • The three-dimensional arrangement of the ribosome positions rplJ near critical 23S rRNA domains involved in antibiotic binding

• Compensatory Mechanisms:

  • Some rplJ modifications may serve as compensatory mutations that offset fitness costs associated with primary 23S rRNA mutations

  • 23S rRNA mutations like G2576T (the most common clinically observed mutation) may interact with subtle changes in ribosomal proteins like L10

  • Gene dose effects in 23S rRNA mutations (which occur in a gene dose-dependent fashion) may be modulated by ribosomal protein alterations

• Structural Insights:

  • Crystal structure analysis using coordinates from D. radiodurans and H. marismortui LZD-bound 50S ribosomal subunits provides insights into these interactions

  • The high conservation of ribosomal regions across species allows for extrapolation of structural effects to S. aureus

  • Detailed molecular modeling reveals how mutations in different components collectively alter the antibiotic binding pocket

Methodology for Studying Interactions:

• Serial passage experiments with varying antibiotic selection pressures

• Creation of strains with combinations of defined mutations

• In vitro translation assays to measure functional impacts

• Structural biology approaches including cryo-EM and X-ray crystallography

This field represents an important frontier in antibiotic resistance research, with implications for developing new antimicrobial strategies that can overcome complex resistance mechanisms.

How do post-translational modifications of rplJ affect ribosome function and antibiotic susceptibility?

Post-translational modifications (PTMs) of rplJ represent an emerging area of research with significant implications for ribosome function and antibiotic interactions:

Research Landscape:

• Types of PTMs Observed in Ribosomal Proteins:

  • Methylation, acetylation, and phosphorylation have been documented in various ribosomal proteins

  • While specific PTMs for S. aureus rplJ are still being characterized, research on related ribosomal proteins suggests their importance

  • These modifications can alter protein-protein and protein-rRNA interactions within the ribosome

• Functional Implications:

  • PTMs may fine-tune ribosomal activity under different growth conditions

  • Modifications near antibiotic binding sites can potentially alter susceptibility profiles

  • Changes in ribosome dynamics and assembly may result from specific modification patterns

• Experimental Approaches:

  • Mass spectrometry-based proteomics to map PTM landscapes

  • Site-directed mutagenesis to create PTM-mimicking or PTM-deficient variants

  • Comparative analysis between antibiotic-resistant and susceptible strains

  • In vitro translation assays with modified ribosomes

• Potential Applications:

  • Development of inhibitors targeting enzymes responsible for resistance-conferring PTMs

  • Design of antibiotics that maintain efficacy regardless of PTM status

  • Diagnostic markers based on PTM profiles to predict resistance potential

This research direction may reveal previously unappreciated mechanisms of regulation and resistance, potentially opening new avenues for therapeutic intervention.

What are the methodological challenges in studying rplJ's role in ribosome assembly and quality control?

Investigating rplJ's role in ribosome assembly and quality control presents several methodological challenges that researchers must address:

Technical Challenges and Solutions:

• Ribosome Assembly Dynamics:

  • Challenge: Capturing transient intermediates in ribosome assembly

  • Approaches: Time-resolved cryo-EM, pulse-chase experiments with labeled rplJ, assembly mapping using chemical probing

  • Considerations: Assembly occurs through multiple parallel pathways rather than a strict linear sequence

• Functional Redundancy:

  • Challenge: Distinguishing specific roles of rplJ from other ribosomal proteins

  • Approaches: Conditional depletion systems, partial function mutants, in vitro reconstitution with defined components

  • Considerations: Complete knockout of essential ribosomal proteins is typically lethal

• Quality Control Mechanisms:

  • Challenge: Identifying quality control checkpoints involving rplJ

  • Approaches: Ribosome profiling under stress conditions, identification of assembly factors that interact with rplJ, characterization of degradation intermediates

  • Considerations: Different quality control systems may operate under various stress conditions

• In vivo vs. In vitro Systems:

  • Challenge: Bridging findings between reconstituted systems and living cells

  • Approaches: Development of semi-in vivo systems, incorporation of cellular extracts, validation across multiple experimental platforms

  • Considerations: In vitro systems may lack important co-factors or cellular conditions

• Technological Approaches:

  • Challenge: Resolving structures of assembly intermediates

  • Approaches: Single-particle cryo-EM, integrative structural biology combining multiple data types, molecular dynamics simulations

  • Considerations: Resolution limitations may obscure critical details of protein-RNA interactions

Addressing these methodological challenges requires interdisciplinary approaches combining structural biology, biochemistry, genetics, and computational modeling. Progress in this area will provide fundamental insights into ribosome biogenesis and potentially reveal new targets for antimicrobial development.

What emerging technologies are advancing our understanding of rplJ function?

Several cutting-edge technologies are transforming our understanding of rplJ function in bacterial ribosomes:

• Cryo-Electron Microscopy Advancements:

  • Near-atomic resolution structures of ribosomes in different functional states

  • Visualization of rplJ interactions with other ribosomal components and factors

  • Capturing conformational changes during translation and in response to antibiotics

• Ribosome Profiling and NGS Applications:

  • Genome-wide analysis of translation efficiency in rplJ mutants

  • Identification of genes differentially affected by rplJ modifications

  • Correlation between ribosome occupancy and antibiotic resistance profiles

• CRISPR-Based Approaches:

  • Precise genome editing to create rplJ variants

  • CRISPRi for conditional knockdown studies

  • High-throughput screening of rplJ mutations for phenotypic effects

• Single-Molecule Techniques:

  • Direct observation of ribosome dynamics in real-time

  • Quantification of rplJ's contribution to ribosomal subunit association/dissociation

  • Measurement of antibiotic binding kinetics in wild-type versus mutant ribosomes

• Integrative Structural Biology:

  • Combining multiple structural techniques (X-ray, NMR, SAXS, cryo-EM)

  • Molecular dynamics simulations to predict functional impacts of mutations

  • Artificial intelligence approaches for structure prediction and functional annotation

These technological advances are enabling researchers to address previously intractable questions about rplJ's role in ribosome function and antibiotic resistance mechanisms .

How might understanding rplJ contribute to developing new therapeutic strategies against S. aureus infections?

The detailed characterization of rplJ offers several promising avenues for novel therapeutic development against S. aureus infections:

• Targeted Antibiotic Design:

  • Structure-based design of new ribosome-targeting antibiotics

  • Development of compounds that maintain efficacy against common resistance mutations

  • Dual-targeting strategies that simultaneously engage rplJ and other ribosomal components

• Vaccine Development Strategies:

  • Inclusion of rplJ epitopes in multi-component vaccines

  • Lipidated rplJ formulations to enhance immunogenicity

  • Combined use as both antigen and adjuvant to strengthen immune responses

• Virulence Attenuation Approaches:

  • Identification of rplJ mutations that reduce fitness without compromising growth

  • Development of anti-virulence compounds that target ribosome assembly

  • Exploitation of species-specific features of rplJ for narrow-spectrum therapies

• Combination Therapies:

  • Synergistic drug combinations targeting different aspects of ribosome function

  • Adjuvant compounds that sensitize resistant strains by interfering with resistance mechanisms

  • Sequential therapy protocols designed to prevent resistance emergence

• Diagnostic Applications:

  • Development of rapid tests to identify resistance-associated rplJ mutations

  • Biomarkers based on ribosomal protein modifications

  • Predictive algorithms for resistance emergence based on ribosomal mutation patterns

These therapeutic strategies leverage our growing understanding of rplJ's structural and functional roles, potentially addressing the urgent need for new approaches against multidrug-resistant S. aureus infections .